StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) stock

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3090% above fair value
$294.55−0.48 (-0.16%)

Close on Nov 16, 2026Market cap $520.50BP/E 83.2Yield 2.26%

AbbVie operating margin

Operating margin is operating income as a percentage of revenue.

AbbVie's operating margin for the twelve months ending Jun 30, 2026 was 26.2%. For fiscal 2025 it was 24.6%, against 16.2% the year before. The highest annual figure on record is 39.0% in fiscal 2019.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202524.6%+8.4
FY2024Dec 31, 202416.2%−7.3
FY2023Dec 31, 202323.5%−7.7
FY2022Dec 31, 202231.2%−0.7
FY2021Dec 31, 202131.9%+7.1
FY2020Dec 31, 202024.8%−14.2
FY2019Dec 31, 201939.0%+19.5
FY2018Dec 31, 201819.5%−14.3
FY2017Dec 31, 201733.8%−2.6
FY2016Dec 31, 201636.4%+3.5
FY2015Dec 31, 201533.0%+15.9
FY2014Dec 31, 201417.1%−13.1
FY2013Dec 31, 201330.1%−1.5
FY2012Dec 31, 201231.6%+10.9
FY2011Dec 31, 201120.8%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202637.9%+6.1
Q1 FY2026Mar 31, 202626.6%−1.4
Q4 FY2025Dec 31, 202527.3%+37.2
Q3 FY2025Sep 30, 202512.1%−14.4
Q2 FY2025Jun 30, 202531.7%+4.1
Q1 FY2025Mar 31, 202528.0%+5.2
Q4 FY2024Dec 31, 2024-9.9%−32.2
Q3 FY2024Sep 30, 202426.5%+10.1
Q2 FY2024Jun 30, 202427.6%−4.9
Q1 FY2024Mar 31, 202422.7%+0.1
Q4 FY2023Dec 31, 202322.3%−14.0
Q3 FY2023Sep 30, 202316.4%−14.7
Q2 FY2023Jun 30, 202332.5%+10.0
Q1 FY2023Mar 31, 202322.6%−12.2
Q4 FY2022Dec 31, 202236.4%+2.3
Q3 FY2022Sep 30, 202231.1%+1.1
Q2 FY2022Jun 30, 202222.6%−9.2
Q1 FY2022Mar 31, 202234.8%+3.3
Q4 FY2021Dec 31, 202134.1%+7.0
Q3 FY2021Sep 30, 202130.0%+4.8
Q2 FY2021Jun 30, 202131.8%+24.6
Q1 FY2021Mar 31, 202131.5%−10.3
Q4 FY2020Dec 31, 202027.1%−18.4
Q3 FY2020Sep 30, 202025.2%−5.6
Q2 FY2020Jun 30, 20207.2%−34.0
Q1 FY2020Mar 31, 202041.8%+3.4
Q4 FY2019Dec 31, 201945.5%+74.8
Q3 FY2019Sep 30, 201930.9%−7.5
Q2 FY2019Jun 30, 201941.2%+7.8
Q1 FY2019Mar 31, 201938.5%+1.9
Q4 FY2018Dec 31, 2018-29.4%−52.4
Q3 FY2018Sep 30, 201838.4%−0.2
Q2 FY2018Jun 30, 201833.4%−5.0
Q1 FY2018Mar 31, 201836.6%−0.2
Q4 FY2017Dec 31, 201723.0%−11.0
Q3 FY2017Sep 30, 201738.5%+1.8
Q2 FY2017Jun 30, 201738.3%–
Q1 FY2017Mar 31, 201736.8%–
Q4 FY2016Dec 31, 201634.0%–
Q3 FY2016Sep 30, 201636.7%–

More AbbVie figures

See a number that looks wrong?